2024
Sanger sequencing and deconvolution of polyclonal infections: a quantitative approach to monitor drug-resistant Plasmodium falciparum
Maiga H, Morrison R, Duffy P. Sanger sequencing and deconvolution of polyclonal infections: a quantitative approach to monitor drug-resistant Plasmodium falciparum. EBioMedicine 2024, 103: 105115. PMID: 38636200, PMCID: PMC11031737, DOI: 10.1016/j.ebiom.2024.105115.Peer-Reviewed Original ResearchConceptsDrug resistance genesNational Institutes of HealthBill & Melinda Gates FoundationPlasmodium falciparumAnti-malarial drug resistanceDrug-resistant Plasmodium falciparumSanger sequencingSanger sequencing of PCR ampliconsAntimalarial drug sensitivityAnti-malarial resistanceMalaria-endemic regionsNational Institute of AllergySequencing of PCR ampliconsInstitute of AllergyPfdhps allelesPfdhps genesUS National Institutes of HealthPublic health problemPolyclonal infectionsSequencing chromatogramsField samplesPopulation-based surveyDrug sensitivityMelinda Gates FoundationDrug resistanceEstimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study
Hartner A, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers M, Ferrari M, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore S, Nayagam S, Papadopoulos T, Perkins T, Portnoy A, Minh Q, Vynnycky E, Winter A, Burrows H, Chen C, Clapham H, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim J, Koh J, Lopman B, Pitzer V, Tam Y, Lambach P, Sim S, Woodruff K, Ferguson N, Trotter C, Gaythorpe K. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study. The Lancet Global Health 2024, 12: e563-e571. PMID: 38485425, PMCID: PMC10951961, DOI: 10.1016/s2214-109x(23)00603-4.Peer-Reviewed Original ResearchConceptsCatch-up activitiesVaccine-preventable disease burdenCatch-upVaccine Impact Modelling ConsortiumImmunisation servicesMiddle-income countriesEffectiveness of HPV vaccinationVaccine effectivenessAffected cohortBill & Melinda Gates FoundationImmunisation coverageLow-incomeLong-term effectsWHO-UNICEFDisease burdenVaccination coverageCalendar yearImmunisation effortsMelinda Gates FoundationMitigation measuresCountriesYears of vaccinationYellow fever vaccine
2019
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
collaborators G, Frank T, Carter A, Jahagirdar D, Biehl M, Douwes-Schultz D, Larson S, Arora M, Dwyer-Lindgren L, Steuben K, Abbastabar H, Abu-Raddad L, Abyu D, Adabi M, Adebayo O, Adekanmbi V, Adetokunboh O, Ahmadi A, Ahmadi K, Ahmadian E, Ahmadpour E, Ahmed M, Akal C, Alahdab F, Alam N, Albertson S, Alemnew B, Alene K, Alipour V, Alvis-Guzman N, Amini S, Anbari Z, Anber N, Anjomshoa M, Antonio C, Arabloo J, Aremu O, Areri H, Asfaw E, Ashagre A, Asmelash D, Asrat A, Avokpaho E, Awasthi A, Awoke N, Ayanore M, Azari S, Badawi A, Bagherzadeh M, Banach M, Barac A, Bärnighausen T, Basu S, Bedi N, Behzadifar M, Bekele B, Belay S, Belay Y, Belayneh Y, Berhane A, Bhat A, Bhattacharyya K, Biadgo B, Bijani A, Bin Sayeed M, Bitew H, Blinov A, Bogale K, Bojia H, Nagaraja S, Butt Z, Cahuana-Hurtado L, Rincon J, Carvalho F, Chattu V, Christopher D, Chu D, Crider R, Dahiru T, Dandona L, Dandona R, Daryani A, Neves J, De Neve J, Degenhardt L, Demeke F, Demis A, Demissie D, Demoz G, Deribe K, Jarlais D, Dhungana G, Diaz D, Djalalinia S, Phuc H, Doan L, Duber H, Dubey M, Dubljanin E, Duken E, Adema B, Effiong A, Eftekhari A, Zaki M, El-Jaafary S, El-Khatib Z, Elsharkawy A, Endries A, Eskandarieh S, Eyawo O, Farzadfar F, Fatima B, Fentahun N, Fernandes E, Filip I, Fischer F, Folayan M, Foroutan M, Fukumoto T, Fullman N, Garcia-Basteiro A, Gayesa R, Gebremedhin K, Gebremeskel G, Gebreyohannes K, Gedefaw G, Gelaw B, Gesesew H, Geta B, Gezae K, Ghadiri K, Ghashghaee A, Ginindza T, Gugnani H, Guimarães R, Haile M, Hailu G, Haj-Mirzaian A, Haj-Mirzaian A, Hamidi S, Handanagic S, Handiso D, Hanfore L, Hasanzadeh A, Hassankhani H, Hassen H, Hay S, Henok A, Hoang C, Hosgood H, Hosseinzadeh M, Hsairi M, Ibitoye S, Idrisov B, Ikuta K, Ilesanmi O, Irvani S, Iwu C, Jacobsen K, James S, Jenabi E, Jha R, Jonas J, Shushtari Z, Kabir A, Kabir Z, Kadel R, Kasaeian A, Kassa B, Kassa G, Kassa T, Kayode G, Kebede M, Kefale A, Kengne A, Khader Y, Khafaie M, Khalid N, Khan E, Khan G, Khan J, Khang Y, Khatab K, Khazaei S, Khoja A, Kiadaliri A, Kim Y, Kisa A, Kisa S, Kochhar S, Komaki H, Koul P, Koyanagi A, Defo B, Kumar G, Kumar M, Kuupiel D, Lal D, Lee J, Lenjebo T, Leshargie C, Macarayan E, Maddison E, Razek H, Magis-Rodriguez C, Mahasha P, Majdan M, Majeed A, Malekzadeh R, Manafi N, Mapoma C, Martins-Melo F, Masaka A, Mayenga E, Mehta V, Meles G, Meles H, Melese A, Melku M, Memiah P, Memish Z, Mena A, Mendoza W, Mengistu D, Mengistu G, Meretoja T, Mestrovic T, Miller T, Moazen B, Mohajer B, Mohamadi-Bolbanabad A, Mohammad K, Mohammad Y, Darwesh A, Mezerji N, Mohammadi M, Mohammadibakhsh R, Mohammadoo-Khorasani M, Mohammed J, Mohammed S, Mohebi F, Mokdad A, Moodley Y, Moossavi M, Moradi G, Moradi-Lakeh M, Moschos M, Mossie T, Mousavi S, Muchie K, Muluneh A, Muriithi M, Mustafa G, Muthupandian S, Nagarajan A, Naik G, Najafi F, Nazari J, Ndwandwe D, Nguyen C, Nguyen H, Nguyen S, Nguyen T, Ningrum D, Nixon M, Nnaji C, Noroozi M, Noubiap J, Shiadeh M, Obsa M, Odame E, Ofori-Asenso R, Ogbo F, Okoro A, Oladimeji O, Olagunju A, Olagunju T, Olum S, Asante K, Oren E, Otstavnov S, Mahesh P, Padubidri J, Pakhale S, Pakpour A, Patel S, Paulos K, Pepito V, Peprah E, Piroozi B, Pourshams A, Qorbani M, Rabiee M, Rabiee N, Radfar A, Rafay A, Rafiei A, Rahim F, Rahimi-Movaghar A, Rahimi-Movaghar V, Rahman S, Ranabhat C, Rawaf S, Reis C, Renjith V, Reta M, Rezai M, González C, Roro E, Rostami A, Rubino S, Moghaddam S, Safari S, Sagar R, Sahraian M, Salem M, Salimi Y, Salomon J, Sambala E, Samy A, Sartorius B, Satpathy M, Sawhney M, Sayyah M, Schutte A, Sepanlou S, Seyedmousavi S, Shabaninejad H, Shaheen A, Shaikh M, Shallo S, Shamsizadeh M, Sharifi H, Shibuya K, Shin J, Shirkoohi R, Silva D, Silveira D, Singh J, Sisay M, Sisay M, Sisay S, Smith A, Sokhan A, Somayaji R, Soshnikov S, Stein D, Sufiyan M, Sunguya B, Sykes B, Tadesse B, Tadesse D, Tamirat K, Taveira N, Tekelemedhin S, Temesgen H, Tesfay F, Teshale M, Thapa S, Tlaye K, Topp S, Tovani-Palone M, Tran B, Tran K, Ullah I, Unnikrishnan B, Uthman O, Veisani Y, Vladimirov S, Wada F, Waheed Y, Weldegwergs K, Weldesamuel G, Westerman R, Wijeratne T, Wolde H, Wondafrash D, Wonde T, Wondmagegn B, Yeshanew A, Yilma M, Yimer E, Yonemoto N, Yotebieng M, Youm Y, Yu C, Zaidi Z, Zarghi A, Zenebe Z, Zewale T, Ziapour A, Zodpey S, Naghavi M, Vollset S, Wang H, Lim S, Kyu H, Murray C. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The Lancet HIV 2019, 6: e831-e859. PMID: 31439534, PMCID: PMC6934077, DOI: 10.1016/s2352-3018(19)30196-1.Peer-Reviewed Original ResearchConceptsAntiretroviral therapy coverageNational Institutes of HealthCoverage of antiretroviral therapyGlobal Burden of DiseaseAntiretroviral therapyAntiretroviral therapy scale-upSouthern Sub-Saharan AfricaAntenatal care clinicsReducing HIV-related mortalityNational Institute on AgingProgress of preventionHIV prevention initiativesHIV-related mortalityRisk Factors StudyPrevalence of HIVVital registration dataNational Institute of Mental HealthInstitute of Mental HealthBurden of diseaseInstitute on AgingPopulation-based seroprevalence surveysBill & Melinda Gates FoundationPopulation of peopleUS National Institutes of HealthCases of HIV
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply